Blister package for pharmaceutical cartridges

US8925726B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-8925726-B2
Application numberUS-201213436698-A
CountryUS
Kind codeB2
Filing dateMar 30, 2012
Priority dateApr 1, 2011
Publication dateJan 6, 2015
Grant dateJan 6, 2015

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Blister packages are described that comprise a blistered base sheet including one or more cavities and a lid bonded to said blister package. The cavities may include a void, a dome structure, and a shelf. The shelf may be configured to hold a cartridge, and the cartridge may contain a pharmaceutical formulation.

First claim

Opening claim text (preview).

I claim: 1. A blister package comprising a blistered base sheet comprising one or more cavities having a void, a dome structure, a shelf and a cartridge containing a pharmaceutical formulation comprising a diketopiperazine and an active ingredient; a lid bonded to said blister package; wherein the one or more cavities have an exterior surface and interior surface, and wherein the shelf includes an indentation in the exterior surface. 2. The blister package of claim 1 , wherein the indentation is a cartridge top retaining feature in the interior surface of the cavities. 3. The blister package of claim 1 , wherein the shelf extends from the dome structure and forms a substantially flat end of the one or more cavities and said indentation which forms a cartridge retaining feature in the interior surface of the one or more cavities. 4. The blister package of claim 1 , wherein the cartridge comprising a container and a lid or top that extends over the container. 5. The blister package of claim 1 , wherein the diketopiperazine is bis-3,6-(N-fumaryl-4-aminobutyl)-2,5-diketo-diketopiperazine. 6. The blister package of claim 1 , wherein the active ingredient is a peptide, protein, a small molecule or a nucleic acid. 7. The blister package of claim 1 , wherein the active ingredient is selected from the group consisting of insulin, glucagon like peptide 1, glucagon, oxytocin, oxyntomodulin, peptide YY, sumatriptan, a peptidyl peptidase IV inhibitor, parathyroid hormone, deoxyribonuclease I and active fragments or analogs thereof. 8. The blister package of claim 7 wherein the active ingredient is at least one of insulin, glucagon like peptide 1, glucagon, and a peptidyl peptidase IV inhibitor. 9. The blister package of claim 8 wherein the active ingredient is insulin. 10. The blister package of claim 8 wherein the active ingredient is glucagon like peptide 1. 11. The blister package of claim 8 wherein the active ingredient is glucagon. 12. The blister package of claim 7 wherein the active ingredient is at least one of oxytocin, oxyntomodulin, and peptide YY. 13. The blister package of claim 12 wherein the active ingredient is oxytocin. 14. The blister package of claim 12 wherein the active ingredient is oxyntomodulin. 15. The blister package of claim 12 wherein the active ingredient is peptide YY. 16. The blister package of claim 1 , wherein the blistered base sheet comprises at least three layers selected from polyvinyl chloride and ACLAR. 17. The blister package of claim 16 , wherein the ACLAR layer forms the middle layer of the blistered base sheet having a thickness of about 230 μm to about 720 μm in thickness. 18. The blister package of claim 1 , wherein the lid comprises a foil comprising one or more layers of selected from aluminum, plastic polymer or co-polymer. 19. The blister package of claim 18 , wherein the lid has a thickness of about 10 μm to 75 μm. 20. The blister package of claim 1 , wherein the blistered base sheet has a thickness greater than 100 μm.

Assignees

Inventors

Classifications

  • Details · CPC title

  • B65D75/368Primary

    the compartments being interconnected, e.g. by small channels · CPC title

  • B65D75/327Primary

    and forming several compartments · CPC title

  • one sheet being rendered plastic, e.g. by heating, and forced by fluid pressure, e.g. vacuum, into engagement with the other sheet and contents, e.g. skin- {, blister-, or bubble-} packaging · CPC title

  • formed in a band or a blisterweb, inserted in a dispensing device or container · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US8925726B2 cover?
Blister packages are described that comprise a blistered base sheet including one or more cavities and a lid bonded to said blister package. The cavities may include a void, a dome structure, and a shelf. The shelf may be configured to hold a cartridge, and the cartridge may contain a pharmaceutical formulation.
Who is the assignee on this patent?
Bergey Michael S, Mannkind Corp
What technology area does this patent fall under?
Primary CPC classification B65D75/368. Mapped technology areas include Operations & Transport.
When was this patent published?
Publication date Tue Jan 06 2015 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).